Abstract:Abstract Introduction Qualitative interviews were conducted to understand experiences of individual with OSA by evaluating the content validity and relevance of 5 patient reported outcome (PRO) measures (PROMIS-Fatigue-8a, the PROMIS-Sleep Impairment-8a, the Epworth Sleepiness Scale (ESS), Patient-Global Impression of Severity (PGI-S)-Fatigue, and Patient-Global Impression of Change (PGI-C)-Fatigue). Methods 3 US sites identified individuals with OSA. Once consented, participants completed an interview containing concept elicitation and cognitive debriefing questions. Interviews were recorded, transcribed, and analyzed using qualitative software. Symptoms and impacts were mapped to the PROs, and a gap analysis was conducted. The study was approved by WCG IRB. Results 30 individuals with OSA (20 current non-PAP users [mean age=55; 50% male] and 10 current PAP users [mean age=52, 80% male]) were interviewed. Non-PAP and PAP users viewed fatigue and feeling sleepy as separate, distinct symptoms. Among non-PAP users the most common symptoms were fatigue (100%), difficulty concentrating (85%), feeling sleepy (75%), dry mouth (60%), interrupted sleep (50%), and headaches (50%). Fatigue (63%) was most bothersome, while 5% rated feeling sleepy as most bothersome. Among PAP users the most common symptoms were fatigue (100%), feeling sleepy (90%), difficulty concentrating (60%), dry mouth/throat (60%), headaches (50%), and interrupted sleep (50%). Fatigue (63%) was most bothersome, while 25% rated feeling sleepy as most bothersome. Non-PAP and PAP users reported negative impacts on daily activities (50% both), physical (60% and 50%, respectively), social (50% both), and emotional functioning (80% and 60%), and relationships (75% and 70%). Impacts on ability to work for pay and work productivity (45% and 70%) were also common. PAP users reported improvements on their ability to do daily activities (80%) and all areas of functioning after initiating PAP (range: 80-100%). In general, participants found these PROs to be clear and appropriate. Fatigue and sleepiness were two of the most common symptoms cited; these concepts are comprehensively covered by these PROs. Conclusion Fatigue and sleepiness should both be assessed in OSA trials and clinical practice. This study provides evidence to support the content validity, clarity, and relevance of the PROMIS-Fatigue-8a, PROMIS-Sleep Impairment-8a, ESS, PGI-S-Fatigue, and PGI-C-Fatigue PROs in an adult OSA population. Support (if any) Funded by Apnimed.

0571 Impact of CPAP Adherence on Objective and Subjective Sleepiness Measures

Associations Between Objective Sleepiness and Cognition Function Before and after CPAP in Obstructive Sleep Apnea Patients

0672 Sleepiness, Psychomotor Vigilance and Cognition in People with OSA Adherent to PAP Therapy

Predictors of the Efficacy for Daytime Sleepiness in Patients with Obstructive Sleep Apnea with Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.

0955 Correlation Between CPAP Use and Symptoms of Depression, Anxiety, and Sleepiness in Patients with OSA

Ventilatory Burden Predicts Change in Sleepiness Following Positive Airway Pressure in Sleep Apnea

0485 Can Hypoxic Burden Predict Improvement in Sleepiness and Cognition in Response to CPAP Treatment in OSA Patients?

The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea

Adherence to CPAP Therapy in Obstructive Sleep Apnea: A Prospective Study on Quality of Life and Determinants of Use

0561 CPAP Tolerance Scores Are Effective in Predicting CPAP Usage in the Short-Term

Correlation between positive airway pressure and medication adherence: the healthy user effect

A pathway underlying the impact of CPAP adherence on intimate relationship with bed partner in men with obstructive sleep apnea

A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea

0460 Dose-response Relationship Between Thalamic Activity During Sustained Attention and Excessive Daytime Sleepiness

Phenotyping patients treated for obstructive sleep apnea with persistent objective impaired alertness or subjective sleepiness

0565 Utilization of Pap Titration as Indicator for Prediction of Pap Adherence

0582 Exploring a Supplemental Measure of CPAP Adherence

Self-Evaluated And Close Relative-Evaluated Epworth Sleepiness Scale Vs. Multiple Sleep Latency Test In Patients With Obstructive Sleep Apnea

0513 MECHANISMS OF CONTINUOUS POSITIVE AIRWAY PRESSURE RESIDUAL SLEEPINESS USING DIFFUSION MAGNETIC RESONANCE IMAGING

0543 The Utility of the PAP NAP for Increasing Patient Utilization of Positive Airway Pressure Therapy

0464 The Impact of Fatigue and Sleepiness on Patients with OSA: A Closer Look with Patient Reported Outcome Measures